The role of extracellular vesicle immune checkpoints in cancer
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxae026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Weiming Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Immune checkpoints (ICPs) play a crucial role in regulating the immune response. In the tumor, malignant cells can hijack the immunosuppressive effects of inhibitory ICPs to promote tumor progression. Extracellular vesicles (EVs) are produced by a variety of cells and contain bioactive molecules on their surface or within their lumen. The expression of ICPs has also been detected in EVs. In vitro and in vivo studies have shown that extracellular vesicle immune checkpoints (EV ICPs) have immunomodulatory effects and are involved in tumor immunity. EV ICPs isolated from the peripheral blood of cancer patients are closely associated with the tumor progression and the prognosis of cancer patients. Blocking inhibitory ICPs has been recognized as an effective strategy in cancer treatment. However, the efficacy of immune checkpoint inhibitors (ICIs) in cancer treatment is hindered by the emergence of therapeutic resistance, which limits their widespread use. Researchers have demonstrated that EV ICPs are correlated with clinical response to ICIs therapy and were involved in therapeutic resistance. Therefore, it is essential to investigate the immunomodulatory effects, underlying mechanisms, and clinical significance of EV ICPs in cancer. This review aims to comprehensively explore these aspects. We have provided a comprehensive description of the cellular origins, immunomodulatory effects, and clinical significance of EV ICPs in cancer, based on relevant studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
- Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing Jiangsu, China.
ORCID-Profile: Mingzhe Ning
Zitieren
APA
Zhang, W., Ou, M., Yang, P., & Ning, M. (2024). The role of extracellular vesicle immune checkpoints in cancer. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae026
Vancouver
Zhang W, Ou M, Yang P, Ning M. The role of extracellular vesicle immune checkpoints in cancer. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae026
BibTeX
@article{Zhang2024,
author = {Zhang, Weiming and Ou, Mingrong and Yang, Ping and Ning, Mingzhe},
title = {The role of extracellular vesicle immune checkpoints in cancer},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxae026}
}
EUVIMED